Indeed, hematological malignancies were among the first malignancies in which aberrant demethylation status was discovered, and the TET gene was initially defined as a fusion partner of the mixed lineage leukemia (MLL) gene in acute myeloid leukemia (AML). Here, KMT2A is linked to acute myeloid leukemia.